Detection of Kidney Allograft Rejection Using Urinary Chemokines
Journal of the American Society of Nephrology · 2025
DOI: 10.1681/asn.0000000742 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Society of Nephrology, 2025. Verfasst von Valentin Goutaudier und 28 weiteren Autor:innen. Beteiligte Einrichtung: Paris-Cardiovascular Research Center (PARCC) INSERM U970, Paris Institute for Transplantation and Organ Regeneration (PITOR), Université Paris Cité, …. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, Chemokine CXCL10, Chemokine CXCL9. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Agence Nationale de la Recherche, INSERM-Action thématique incitative sur program Avenir (ATIP-Avenir), French-Speaking Society of Transplantation, French Foun…, Agence Nationale de la Recherche, INSERM-Action thématique incitative sur program Avenir.
Abstract (Originalsprache)
Key Points Urinary C-X-C motif ligand 9 demonstrated moderate clinical utility beyond standard-of-care monitoring in detecting overall allograft rejection. Urinary C-X-C motif ligand 10 did not show additional value in detecting overall allograft rejection beyond standard-of-care monitoring. In sensitivity analyses limited to acute/active rejection and single biopsies per patient, urinary C-X-C motif ligand 9 and C-X-C motif ligand 10 showed no added value.
Background
Urinary chemokines C-X-C motif ligand 9 (CXCL9) and C-X-C motif ligand 10 (CXCL10) have shown promise for detecting kidney allograft rejection, but the demonstration of their added value beyond standard-of-care patient monitoring requires further study.
Methods
We prospectively enrolled adult patients who underwent kidney transplantation in seven transplant referral centers between July 2018 and December 2019 (ClinicalTrials.gov, NCT03582436). We quantified urinary CXCL9 and CXCL10 protein levels at the time of kidney allograft biopsies in the first year post-transplantation using an automated immunoassay platform. The primary outcome was allograft rejection defined according to the international Banff 2019 classification.
Results
Overall, 733 kidney transplant patients (64% male, 36% female) were included in the main analysis, with 1549 biopsies paired with a urine sample. The cumulative incidence of rejection was 10%. For detecting allograft rejection, urinary CXCL9 and CXCL10 demonstrated areas under the receiver operating characteristic curve (AUROC) of 0.70 (95% confidence interval [CI], 0.64 to 0.75) and 0.64 (95% CI, 0.58 to 0.71), respectively. Adding urinary CXCL9 to a standard-of-care model improved discrimination for allograft rejection (AUROC 0.75 [percentile bootstrap CI, 0.70 to 0.79] to 0.78 [percentile bootstrap CI, 0.73 to 0.83]), while urinary CXCL10 did not. There was no improvement of overall fit with the addition of urinary CXCL9 (Brier score changed from 0.056 [95% CI, 0.046 to 0.067] to 0.054 [95% CI, 0.045 to 0.064]), as this tended to overestimate the risk for allograft rejection. In sensitivity analyses restricting to only acute/active forms of rejection or to a single randomly selected biopsy per patient, urinary chemokines did not show additional value beyond the standard of care. In addition, existing chemokine-based models showed low-to-moderate performance for the detection of allograft rejection.
Conclusions
Urinary CXCL9 demonstrated limited clinical utility, while urinary CXCL10 provided no additional value beyond standard-of-care monitoring for detecting allograft rejection within the first year after kidney transplantation. Clinical Trial registry name and registration number: ClinicalTrials.gov, NCT03582436.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Paris-Cardiovascular Research Center (PARCC) INSERM U970, Paris Institute for Transplantation and Organ Regeneration (PITOR), Université Paris Cité, Paris, France.
- Clinical Investigation Center CIC1418, DMU CARTE, European Georges Pompidou Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
- Department of Kidney Transplantation, Necker Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
- Clinical Trial Unit Hospital, Lariboisière Saint-Louis AP-HP, Paris Cité University, Paris, France.
- Centre Hospitalier Universitaire Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, Nantes Université, Nantes, France.
- Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
ORCID-Profile: Valentin Goutaudier, Olivier Aubert, Maud Racapé, Marta Sablik, Olivia Rousseau, Gillian Divard, Béatrice Charreau, Didier Bouton, Pierre-Antoine Gourraud, Magali Giral, Moglie Le Quintrec, Emmanuel Morelon, Lionel Couzi, Carmen Lefaucheur, Nassim Kamar, Sophie Brouard, Dany Anglicheau
Förderung
- Agence Nationale de la Recherche, INSERM-Action thématique incitative sur program Avenir (ATIP-Avenir), French-Speaking Society of Transplantation, French Foun…
- Agence Nationale de la Recherche
- INSERM-Action thématique incitative sur program Avenir
- French-Speaking Society of Transplantation
- French Foundation for Medical Research
- Université Paris Cité
Zitieren
APA
Goutaudier, V., Aubert, O., Racapé, M., Truchot, A., Sablik, M., Raynaud, M., Vicaut, É., Rousseau, O., Elias, M., Divard, G., Papuchon, E., Danger, R., Charreau, B., Bouton, D., Nguyen-Khoa, T., Randoux-Lebrun, C., Taupin, J. L., Gourraud, P. A., Giral, M., …, & KTD-Innov Consortium (2025). Detection of Kidney Allograft Rejection Using Urinary Chemokines. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000000742
Vancouver
Goutaudier V, Aubert O, Racapé M, Truchot A, Sablik M, Raynaud M, et al. Detection of Kidney Allograft Rejection Using Urinary Chemokines. Journal of the American Society of Nephrology. 2025. doi:10.1681/asn.0000000742
BibTeX
@article{Goutaudier2025,
author = {Goutaudier, Valentin and Aubert, Olivier and Racapé, Maud and Truchot, Agathe and Sablik, Marta and Raynaud, Marc and Vicaut, Éric and Rousseau, Olivia and Elias, Michelle and Divard, Gillian and Papuchon, Emmanuelle and Danger, Richard and Charreau, Béatrice and Bouton, Didier and Nguyen-Khoa, Thao and Randoux-Lebrun, Christine and Taupin, Jean-Luc and Gourraud, Pierre-Antoine and Giral, Magali and Le Quintrec, Moglie and Morelon, Emmanuel and Couzi, Lionel and Legendre, Christophe and Lefaucheur, Carmen and Kamar, Nassim and Brouard, Sophie and Anglicheau, Dany and Loupy, Alexandre and KTD-Innov Consortium, KTD-Innov Consortium},
title = {Detection of Kidney Allograft Rejection Using Urinary Chemokines},
journal = {Journal of the American Society of Nephrology},
year = {2025},
doi = {10.1681/asn.0000000742}
}
EUVIMED